Latest news with #BIOInternational
Business Journals
2 days ago
- Business
- Business Journals
How the BIO International Convention allows the United Kingdom to show it's open for business
The annual BIO International conference is large. Very large, with around 20,000 leaders from the global biotech ecosystem in attendance. So it's no surprise that for years, the UK's Department for Business and Trade (DBT) and its partner, the Association of the British Pharmaceutical Industry, have hosted a UK Pavilion featuring UK innovators in the biotech industry, research and development. "BIO is a big conference; it's important for us to be there to show the UK is open for business as every country you can think of is represented,' says Karl Davison, senior business development manager at the National Institute for Health and Care Research (NIHR), one of the organizations on the UK Pavillion. The UK Pavilion isn't just open for business. It's a one-stop shop, making it as easy as possible for potential U.S. and global partners to make fruitful UK connections and gain insight across UK biotech's broad ecosystem of innovation and resources. "Our collaboration with the DBT on the UK Pavilion is central to our global engagement strategy,' says James Richards, Ph.D., NIHR's head of business development. 'It allows international companies to access a uniquely streamlined experience: in a single, highly productive meeting, they can speak to UK experts on regulation, life sciences policy, how to set up a commercial base in the UK — and with the NIHR about our world-class research infrastructure. Together, we can provide a comprehensive introduction to the UK's life sciences ecosystem." Making connections Since 2015, 39 export partnerships, totalling nearly $300 million, have resulted from DBT support at the yearly BIO Conference. So, companies like hVIVO, a full-service Contract Research Organization and a global leader in human challenge trials, will be returning to the UK Pavilion with DBT, as will Merxin Ltd, a UK biotech research company specializing in dry powder and soft mist inhalers. "We had an extraordinary run last year at BIO International in San Diego," says Philippe Rogueda, chief business officer and chief operating officer at Merxin Ltd. "BIO is one of the most exciting events for new molecule therapies investment in North America, probably in the world. We met about 250 people and had 40 arranged meetings with a range of companies, which were in different stages of clinical development, as well as investors. Being part of the UK Pavilion with the UK Department of Business and Trade is great; there is a real benefit to having a physical presence at BIO." William Ward, business development manager at Merxin Ltd, adds: "You get the chance to meet some of these really innovative, emerging biotechs as well as big pharmas at BIO, and the risk appetite is there. Last year, we had several conversations with companies who maybe hadn't considered inhalation as their typical route of administration but were very keen to understand how they could utilize Merxin's devices to advance their therapies. That type of mindset and innovation is where some great partnerships can be formed." The benefits go both ways. "The ability to have face-to-face conversations makes for an impactful conference,' says Davison. 'Sometimes companies don't realize how much we can do to support them and, if we can provide them with a golden nugget of information, it makes the UK a stronger prospect for their next clinical trial." The UK-U.S. partnership: Greater together With its world-leading research institutions, innovative biotech companies, and commitment to science and technology advancement, the UK has a strong offer, including: The UK tech sector is one of only three nations valued at over $1 trillion, making it the third largest tech ecosystem in the world behind only the U.S. and China In 2023, UK startups raised the most venture capital in Europe The UK is home to four of the top 10 global universities for life sciences and medicine and leverages the expertise of the National Health Service (NHS), which offers an unmatched wealth of health data for innovative research The UK ranks third globally for elite artificial intelligence (AI) talent, number of AI startups, inward investment into AI and government readiness for AI adoption — with a sector valued at $92 billion. As global leaders in science and technology, the U.S. and UK make natural partners in R&D. In fact, more than 10% of U.S. foreign R&D investment goes into the UK, the largest share of any country where U.S. businesses invest in research and innovation. And following the landmark economic deal between the U.S. and UK earlier this year, the UK is working toward building a broad and deep a UK-U.S. science and technology partnership through which these science-rich nations will collaborate in biotech and life sciences, as well as quantum computing, nuclear fusion, and aerospace. If you're a U.S. investor or company that would like to learn more about how partnering with UK biotech can grow your business, stop by the UK Pavilion at BIO (Hall A, stand 765), or contact a DBT sector specialist near you who can connect you with UK suppliers and investment opportunities. Email us to learn more. The UK's Department for Business and Trade is an economic growth department. We ensure fair, competitive markets at home, secure access to new markets abroad, and support businesses to invest, export, and grow. Our priorities are the Industrial Strategy, Make Work Pay, the Trade Strategy and the Plan for Small Business.
Business Journals
13-06-2025
- Business
- Business Journals
Five things: BIO in Boston, 'Loganing,' Petri Dish and Best Places to Work rankings
Good morning, Boston. Here are the five things you need to know in local business news to start your busy Friday, and one more thing to know: Tomorrow marks yet another Saturday with rain in the forecast. 1. Forget 'Storrowing.' Massport deals with 'Loganing' MassPort is taking steps to address an uptick in "too-tall" truck strikes on road signs and overpasses at Logan International Airport, Isabel Hart reports. GET TO KNOW YOUR CITY Find Local Events Near You Connect with a community of local professionals. Explore All Events 2. BIO is nigh upon us BIO International, the global convention for life sciences companies, investors, partners and the state and national economic development officials wooing them, is arriving in Boston starting on Monday. Hannah Green has all you need to know about what it means to host this major trade show, and spoke with one of the original architects of the Massachusetts life sciences industry. 3. Alnylam, GSK, Vertex pledge Mass. jobs for tax incentives Green also reports that 33 life sciences companies are slated to receive $29.9 million in tax incentives in exchange for creating over 1,500 new jobs in Massachusetts. Do you like the Five Things? Make sure to subscribe — free — to our Morning Edition emails so you have it in your inbox each day. 4. Boston vaccine developer acquired for $1.25B And because she's not busy enough, Green also reports that CureVac NV, whose U.S. headquarters is in Boston, is being acquired by BioNTech in a deal valued at $1.25 billion. 5. How small businesses can use AI Small businesses are learning to put AI to work as an extra pair of hands through a partnership with a local nonprofit led by a Boston University researcher and the Black Economic Council of Massachusetts, Eli Chavez reports. What else you need to know By the numbers The Petri Dish A spinout from Scorpion Therapeutics debuted with $177 million, Bicara Therapeutics doubled its footprint, and the Mass. Life Sciences Center gave out health equity awards of $50,000 — all in the latest biotech news roundup from Hannah Green. On the radio This morning at 6:45 or 8:45 on GBH Radio's "Morning Edition" you can hear Jess Aloe report the "Boston Business Journal Minute" — a quick highlight of the week's top stories. Not near the radio? Listen here anytime. Listen this Sunday to the New England Business Report, where I will be discussing the news of the week with Kim Carrigan and Joe Shortsleeve. Tune in at 8 a.m. on WRKO-AM 680 or listen here. Quotable 'I feel like the grandmother who sits at the soccer game, and I look out there and I see my little grandchild running up and down the field and scoring goals and being a star player. And nobody knows that that's my grandchild, but I know.' — Susan Windham-Bannister, former head of the Mass. Life Sciences Center, reflecting on the growth of the industry since 2008. Today in history On this day in 1995, Alanis Morissette released her breakthrough album, Jagged Little Pill. (On This Day In Music) Birds I'm seeing Tree Swallow in Belle Isle Marsh, East Boston What's good on WERS-FM Brilliant Mistake, by Elvis Costello What I'm watching Kaos, on Netflix Welcome to the jungle Whether you like Guns N' Roses, or not, you couldn't ignore the jungle theme at last night's 23rd annual Boston Business Journal Best Places to Work ceremony and reception. Stay tuned for photos from the event, which will be posted to our site later today, but for those of you wondering which companies ranked highest in their size category, you can find all the 2025 Best Places to Work here or scroll below for the rankings themselves. As I mentioned, the event was 'jungle-themed,' meaning lots of vegetation, animals and reptiles, stilt-walking giraffes, elephants and lions, and more. We had over 300 nominations this year, and from those, Massachusetts-based employees were surveyed by Quantum Workplace, our longtime data partner, and their responses led us to expand this year's ranking from 80 companies to 100 qualifying as Best Places to Work. If you love your company and think it could be among the top-ranked Best Places to Work, be sure to contact Sean McFadden, our associate editor, research, who will make sure you're included in the survey process next year. PARTING SHOT You know how much I love a wildlife webcam. Well, these researchers are using hidden cameras in the jungles of Central America to get help from the animals themselves in documenting the rainforest's incredible variety of species. Subscribe to the Morning Edition or Afternoon Edition for the business news you need to know, all free. Best Places to Work: Extra Large Companies (500 employees and up) Score Rank Prior Rank Company 1 1 VHB 2 6 Arbella Insurance Group 3 3 Vertex Pharmaceuticals Inc. View this list Best Places to Work: Large Companies (250 to 499 employees) Score Rank Prior Rank Company 1 2 Wasabi Technologies 2 2 CyberArk 3 3 Weston & Sampson View this list Best Places to Work: Medium Companies (100 to 249 employees) Score Rank Prior Rank Company 1 1 SEI - Boston 2 2 RapDev LLC 3 2 J. Calnan & Associates View this list Best Places to Work: Small Companies (50 to 99 employees) Score Rank Prior Rank Company 1 1 Tines 2 3 Ligris + Associates PC 3 3 Your Part-Time Controller LLC View this list
Business Wire
10-06-2025
- Business
- Business Wire
Nu-Tek BioSciences to Showcase Leadership in Animal-Free Cell Culture Solutions at BIO International Convention 2025
MINNEAPOLIS--(BUSINESS WIRE)--Nu-Tek BioSciences, the market leader in high-performance, animal-origin-free (AOF) yeast extracts and peptones for the biopharmaceutical industry, today announced its participation in the BIO International Convention 2025. The premier global event for biotechnology, innovation, and collaboration will take place from June 16-19, 2025, in Boston, MA. Nu-Tek BioSciences will be a key representative at Booth 453 as part of the Minnesota Delegation via the Minnesota Department of Employment and Economic Development (MN DEED), alongside other esteemed biotech innovators from the state. This underscores Nu-Tek's commitment to advancing biomanufacturing worldwide. "BIO International is a vital platform for connecting with leaders across the global biopharmaceutical landscape," said Tom Yezzi, CEO of Nu-Tek BioSciences. "As the market leader in animal-free cell culture ingredients, we are uniquely positioned to address the industry's growing demands for yeast and plant-based peptones. We look forward to engaging with colleagues to discuss how our products and capabilities can support their business goals." Nu-Tek's CEO and senior leadership will be available throughout the conference to discuss Nu-Tek's extensive portfolio of animal-free specialty yeast extracts and plant-based peptones, which are instrumental in producing novel therapies such as biologics, vaccines, and cancer treatments. Nu-Tek's products are renowned for their consistent performance, robust supply chain, and ability to mitigate risks associated with traditional animal-derived media components like Fetal Bovine Serum (FBS). Nu-Tek BioSciences invites all interested attendees to visit Minnesota Delegation Booth 453 to learn more about Nu-Tek's innovative solutions; attendees may also schedule time with the team directly through sales@ About Nu-Tek BioSciences: Nu-Tek BioSciences is the market leader in the development and manufacturing of high-quality, 100 % animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility in Austin, Minnesota, dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek's innovative solutions are crucial for cell culture and microbial fermentation, enabling the production of vaccines, cancer therapeutics, monoclonal antibodies, and other vital biologics while ensuring supply consistency customer compliance.
Yahoo
29-05-2025
- Business
- Yahoo
Women In Bio Announces Presentations and Networking Opportunities at BIO International 2025
BOSTON, May 29, 2025 /PRNewswire/ -- Women In Bio (WIB) is excited to host four engaging events at the 2025 BIO International conference in Boston June 16-19,2025. Building on years of successful programming at BIO, WIB will host four unique and engaging events designed to connect, inspire, and elevate women across the industry. These gatherings are open to WIB members, supporters, advocates, and guests who are passionate about advancing women's leadership in life sciences. Monday, June 16 2025 — 8:00am-10:00am EDT — EWIB Breakfast: The Fight for Women in Science – Past and Present (a Fireside Chat)Join us for an inspiring conversation with Dr. Nancy Hopkins and Pulitzer Prize-winning journalist Kate Zernike, author of The Exceptions, the acclaimed book chronicling the groundbreaking fight for gender equity at MIT. Discover how a group of women scientists changed the course of history—and why their story still matters today. Tuesday, June 17 2025 — 5:30pm-7:30pm EDT: Plenary Event: Flipping the Script – Powerful Narratives in Women's Health InnovationThe investment landscape today is competitive. The ability to tell a clear, compelling, and consistent story can be the difference between breakthrough funding and another closed door. For women's health founders, crafting that narrative—one that resonates with diverse stakeholders without compromising the core innovation—is both a challenge and a critical opportunity. WIB president, Dianne Keen-Kim will convene a panel to focus o insights from Seema Kumar (CEO, Cure), Kristen Dahlgren (Founder, Cancer Vaccine Coalition, former journalist for Today and NBC Nightly News), and Claire Love (Partner and Leader of Healthcare Deals Strategy, PwC), attendees will leave with actionable tools to sharpen their own narratives—and help fuel the next era of investment in women's health. Wednesday, June 18 2025 — 2:00pm-3:00pm EDT: Speed Networking at the Convention - On the Exhibition Floor Booth #3584This high-energy gathering is all about sparking real connections among women and allies in the life sciences world. Here's how it works: participants will take part in rapid-fire networking rounds, with just 90 seconds to introduce themselves, share insights, and explore potential synergies before rotating to the next conversation. Please note that a valid BIO pass is required to access the convention floor and participate in this exclusive networking event. Wednesday, June 18 2025 — 5:30pm-7:30pm EDT — Sip, Savor & Socialize - Women In Bio Executive Cohorts NetworkingJoin us for an evening of connection and conversation with fellow Women In Bio executive members. Hosted by the WIB Executive Team during the BIO Conference, this relaxed cocktail reception offers an excellent opportunity to network, share insights, and build relationships in a vibrant and welcoming setting. "We're proud to bring together such a compelling slate of events at BIO 2025," said Dianne Keen-Kim, WIB's National President and Board chair. "Whether you're looking to expand your network, hear from industry trailblazers, or discuss how to make an actionable impact in the life sciences, there's a place for you at WIB@BIO." Attendees are encouraged to register in advance for these events, as space is limited. More details and RSVP links can be found on the Women In Bio website. About Women In Bio:Women In Bio is a dynamic community that empowers women across the life sciences. With nearly 4,000 members and greater than 12,000 individuals engaging in programming across 13 chapters in North America, we foster a vibrant community that connects professionals from diverse backgrounds – from biotech to academia. WIB's programs support women at every stage of their career, from students to board members. Through mentorship, networking and innovative programming, WIB provides touchpoints locally, regionally and nationally to foster innovative thinking across industries and functions, encouraging collaboration. WIB membership is open to all and empowers everyone to be part of a powerful community advancing women in the life sciences. View original content to download multimedia: SOURCE Women In Bio Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
22-05-2025
- Business
- Business Wire
LaVoieHealthScience Returns to BIO International to Lead High Demand Session on Building Successful Presentations for Investors & Strategic Partners
BOSTON--(BUSINESS WIRE)-- LaVoieHealthScience today announced it will lead an educational session at the 2025 BIO International Convention, taking place June 16–19 at the Boston Convention & Exhibition Center. Donna LaVoie, President & CEO of LaVoieHealthScience, who led this workshop at BIO International for 17 years, will join Elise Simard, expert corporate coach and trainer, as co-presenter. 'More important than ever, companies need to articulate their value proposition as well as their competitive position in the marketplace," Donna LaVoie, President & CEO of LaVoieHealthScience Share 'What investors/strategic partners want in 2025: Building presentations for success.' Back by popular demand, this high-impact session returns to BIO and will guide health and science executives through a proprietary framework developed by LaVoieHealthScience: The LHS Fifteen-Slide Presentation ®. These methodologies are designed to help companies clearly articulate the company value proposition, the market problem, the company's value solution, competitive differentiation, regulatory approach, and financial vision—all within a concise 15-slide structure. 'More important than ever, companies need to articulate their value proposition as well as their competitive position in the marketplace. The ability to communicate with clarity, confidence, and strategic intent is a leadership imperative in today's health and science environment,' said Donna LaVoie, President & CEO of LaVoieHealthScience. 'The LHS Fifteen-Slide Presentation ® equips executives with a powerful blueprint to deliver high-impact messages across critical stakeholders—from investors and strategic partners to board members and future employees.' In addition to storytelling strategy, the session will offer practical guidance on enhancing presentation skills, building an authoritative voice, and using emotional intelligence to create alignment between verbal and non-verbal communication. Attendees will leave with actionable techniques to elevate their company story and deliver it with credibility and impact. About LaVoieHealthScience LaVoieHealthScience partners with emerging, government, and commercial organizations to protect reputation and to advance their missions. We are a team of specialized leaders who possess a love for the 'why'. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly related industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, event management, and digital and creative services. For more information, please visit and connect with us on LinkedIn and X.
